BioCardia, Inc.BCDANASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank57
5Y CAGR-27.8%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

5Y CAGR
-27.8%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$1.15M-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$5.09M-13.2%
2020$5.86M-2.4%
2019$6.00M+4.3%
2018$5.76M-10.0%
2017$6.39M+55.7%
2016$4.11M-